LPTX | Leap Therapeutics Inc (NASDAQ:LPTX) Receives Consensus Rating of “Buy” from Analysts

Shares of Leap Therapeutics Inc (NASDAQ:LPTX) have been given an average rating of “Buy” by the seven brokerages that are presently covering the stock, Marketbeat.com reports.One equities research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company.The average twelve-month target price among analysts […]Daily Political